Revenue · 2011–2025
Ligand Pharmaceuticals revenue
$268M+60.4% · FY2025
Ligand Pharmaceuticals (LGND) reported $268M in revenue for fiscal 2025, +60.4% year on year.
| Fiscal year | Revenue | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $268M | +60.4% | Open → |
| FY20242024-12-31 | $167M | +27.3% | Open → |
| FY20232023-12-31 | $131M | −33.1% | Open → |
| FY20222022-12-31 | $196M | −18.8% | Open → |
| FY20212021-12-31 | $242M | +47.7% | Open → |
| FY20202020-12-31 | $164M | +36.0% | Open → |
| FY20192019-12-31 | $120M | −52.2% | Open → |
| FY20182018-12-31 | $251M | +78.2% | Open → |
| FY20172017-12-31 | $141M | +29.5% | Open → |
| FY20162016-12-31 | $109M | +51.5% | Open → |
| FY20152015-12-31 | $71.9M | +11.4% | Open → |
| FY20142014-12-31 | $64.5M | +31.8% | Open → |
| FY20132013-12-31 | $49.0M | +56.0% | Open → |
| FY20122012-12-31 | $31.4M | +4.5% | Open → |
| FY20112011-12-31 | $30.0M | — | Open → |
Revenue — Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026 · 2011–2025 compound annual growth +16.9%
Revenue at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ligand Pharmaceuticals revenue |url=https://companiesranked.com/en/company/ligand-pharmaceuticals/revenue |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ligand Pharmaceuticals revenue. CompaniesRanked. https://companiesranked.com/en/company/ligand-pharmaceuticals/revenueBibTeX
@misc{companiesranked-en-company-ligand-pharmaceuticals-revenue-2026,
author = {{CompaniesRanked}},
title = {{Ligand Pharmaceuticals revenue}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ligand-pharmaceuticals/revenue}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0000886163-26-000006 · February 27, 2026
{{cite web |title=Ligand Pharmaceuticals revenue — 10-K (0000886163-26-000006) |url=https://www.sec.gov/Archives/edgar/data/886163/000088616326000006/lgnd-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-27}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.